All about Attention-Deficit/Hyperactivity Disorder
The Attention-Deficit/Hyperactivity Disorder Resource page is a collaborative project of NeedyMeds and the . It is intended to provide information on Attention-Deficit/Hyperactivity Disorder and to streamline and simplify the way those with Attention-Deficit/Hyperactivity Disorder may find assistance paying for their medications.
According to the National Alliance on Mental Illness, Attention-deficit/hyperactivity disorder (ADHD) is an illness characterized by inattention, hyperactivity and impulsivity. The most commonly diagnosed behavior in young persons, ADHD affects an estimated three percent to five percent of school-age children.
Patient Assistance Programs (PAPs) are programs offered by pharmaceutical companies to help those most in need gain access to their medications at no or low cost. Each program has varying financial and insurance guidelines - when in doubt, call the program. To find the specific PAP information for a specific drug click on the list below. You will then be taken to a listing of all the programs available for that medication.
NeedyMeds neither promotes nor endorses the therapies listed below nor the supporters of this page. This page is for educational purposes only.
Medications used in the treatment of Attention-Deficit/Hyperactivity Disorder
Blue names means the drug is available through a Patient Assistance Program; an asterisk indicates the drug is not currently available through a patient assistance program:
|Adderall (dextroamphetamine and amphetamine)* |
Dexedrine Spansule (dextroamphetamine)*
|Dextrostat (dextroamphetamine)* |
Focalin XR (dexmethyiphenidate hydrochloride)
|Methylin (methylphenidate)* |
Ritalin LA (methylphenidate)*
Vyvanse (lisdexamfetamine dimesylate)